Drugs / KER-047
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05927012 | Nov 2023 → Aug 2025 | iron deficiency anemia | Keros Therapeutics, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KER-047 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05927012 ↗ |
| Modality | Small molecule | — CHEMBL5956963 ↗ |
| Route | Oral | “oral tablet” NCT05927012 ↗ |